Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-04-11
2006-04-11
Yu, Misook (Department: 1642)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S324000, C530S317000
Reexamination Certificate
active
07026281
ABSTRACT:
There is provided a novel series of synthetic analogs of hGH-RH(1–29)NH2. These analogs inhibit the activity of endogenous hGH-RH, and therefore prevent the release of growth hormone. The stronger inhibitory potencies of the new analogs, as compared to previously described ones, results from replacement of various amino acids.
REFERENCES:
patent: WO-95/16707 (1995-06-01), None
Wang, J. et al. 2000 J. Biol. Chem. 275 (1): 507-513.
Section 3.4 Counting, Permutations, and Combinations for counting rules.
Seto et (1990, Biochem. Biophys. Res. Commun 167, 360-336).
Bowie et al (Science, 1990, 247:1306-1310).
Burgess et al (J of Cell Bio. 111:2129-2138, 1990).
Lazar et al (Molecular and Cellular Biology, 1988, 8:1247-1252).
Gura (Science, 1997, 278:1041-1042).
Jain (Sci. Am., 1994, 271:58-65).
Curti (Crit. Rev. in Oncology/Hematology, 1993, 14:29-39).
Hartwell et al (Science, 1997, 278:1064-1068).
Schally Andrew V.
Varga Jozsef
Zarandi Marta
Behr Omri M.
The Administrators of the Tulane Educational Fund
Yu Misook
LandOfFree
Antagonistic analogs of GH-RH inhibiting IGF-I and -II does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antagonistic analogs of GH-RH inhibiting IGF-I and -II, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antagonistic analogs of GH-RH inhibiting IGF-I and -II will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3564407